US$ 27.82
lysosome glutathione Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy Key Mechanisms in Lysosome Stability,
Description
Age 32(3):271282 Schuligoi R, Schmidt R, Geisslinger G, Kollroser M, Peskar BA, Heinemann A (2007) PGD2 metabolism in plasma: kinetics and relationship with bioactivity on DP1 and CRTH2 receptors

Active cancer is a contraindication for most growth-factor-adjacent peptides because we do not want to fertilize a tumor we do not know about

Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor

Isabelle Stoces
